Bio X Cell Announces Board of Director Appointments
A Leading Producer of Monoclonal Antibodies LEBANON,N.H.,Oct. 17,2024-- Bio X Cell,LLC ("BXC" or the "Company"),the world\'s leading producer of monoclonal antibodies for pre-clin
Children education
Special Olympics Calls on G7 Nations to Strengthen Commitment to Disability Inclusion at Historic Summit
CEO Mary Davis Joins US Government Delegation for First-Ever G7 Ministers\' Meeting on Inclusion and Disability
Chinese Global Music Education Association Presents "Light Up Your Life" Charity Concert in Tokyo
HONG KONG,Oct. 17,2024-- The Chinese Global Music Education Association (CGMEA) proudly presented its inaugural charity concert,"Light Up Your Life," at the Andaz Tokyo rooftop,overlooking t
US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute
TAIPEI and SAN DIEGO,Oct. 14,2024-- Senhwa Biosciences,Inc. (TPEx: 6492),a drug development company focusing on first-in-class therapeutics for oncology,rare diseases,and infectious diseases,today an
Vivance Completes Pre-Pivotal Trial of Wearable Dialysis Device; Results to be Shared at ASN Kidney Week 2024
SINGAPORE,Oct. 14,2024-- Vivance,a leader in kidney care innovations,is proud to announce that the next trial phase of the wearable peritoneal dialysis (PD) device,Viva Kompact,has successfully concl
Hyundai Mobis Partners with ZEISS: The Entire Windshield Becomes a Full-Display Screen
Business cooperation agreement signed with German optical companyZEISS for the development of \'Holographic Windshield Display\' technology for vehicles
JETOUR RHD Models Debut in South Africa, Boosting Globalization Through Wildlife Conservation
JOHANNESBURG,Sept. 23,2024--On September 20,2024,local time,JETOUR held a launch event in Johannesburg,South Africa,introducing two RHD models: JETOUR DASHING and X70PLUS,which marks JETOUR\'s acceler
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand
XPOVIO® is the first and only approved XPO1 inhibitor in Thailand. XPOVIO® has been approved for multiple indications in nine markets across the APAC region. Antengene has submitted a new dru
State Grid Shizuishan Power Supply Company: Escort sturgeon farming to help rural revitalization
SHIZUISHAN,China,Sept. 23,2024-- On the edge of the rippling ponds,sturgeon swim merrily,heralding another bumper harvest. Recently,the staff of the State Grid Shizuishan Power Supply Company walked i
Octa wins the 'Most Reliable Broker - Global' award for 2024
KUALA LUMPUR,Malaysia,Sept. 23,2024-- Octa,an international broker in the market since 2011,was recognised as the most reliable Forex broker of 2024 by the prestigious \'Global Forex Awards 2024\' in